iRhythm Technologies
iRhythm Technologies raises $200M Convertible Note at $4B valuation
Quick Facts
iRhythm Technologies: Convertible Note Funding Round
iRhythm Technologies has successfully raised $200M in Convertible Note funding, reaching a valuation of $4B.
Company Overview
Cardiac monitoring solutions
Funding Details
The Convertible Note round was led by CRG LP, with participation from Novo Holdings, Deerfield Management.
Company Information
- Headquarters: 699 8th Street, San Francisco, CA 94103
- Founded: 2006
- Employees: 1000+
- Category: MedTech
Investment
iRhythm Technologies plans to use the funds to accelerate product development, expand its team, and scale operations globally.
About the Investors
- CRG LP: Verified investor in Convertible Note
- Novo Holdings: Verified investor in Convertible Note
- Deerfield Management: Verified investor in Convertible Note
Key Investors
About the Author
Related Company Reports
Galvenize Therapeutics Raises $100M Series C to Transform MedTech
Galvenize Therapeutics has secured $100M Series C in funding to accelerate growth and innovation in the medtech sector. Medical device company developing pulsed electric field therapies for cardiac ablation and tumor treatment...
Reprieve Cardiovascular Raises $61M Series B to Transform MedTech
Reprieve Cardiovascular has secured $61M Series B in funding to accelerate growth and innovation in the medtech sector. Cardiovascular device company developing personalized heart failure therapies and monitoring solutions...
ViCentra Raises $85M Series D to Transform MedTech
ViCentra has secured $85M Series D in funding to accelerate growth and innovation in the medtech sector. Medical device company developing innovative insulin patch pumps for diabetes management...
